Proposed Data Collections Submitted for Public Comment and Recommendations, 73469-73470 [2012-29722]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with
Federal Register / Vol. 77, No. 237 / Monday, December 10, 2012 / Notices
number. You are also solely responsible
for making sure that your comment
doesn’t include any sensitive health
information, like medical records or
other individually identifiable health
information. In addition, don’t include
any ‘‘[t]rade secret or any commercial or
financial information which is obtained
from any person and which is privileged
or confidential * * *, ’’ as provided in
Section 6(f) of the FTC Act, 15 U.S.C.
46(f), and FTC Rule 4.10(a)(2), 16 CFR
4.10(a)(2). If you want the Commission
to give your comment confidential
treatment, you must file it in paper
form, with a request for confidential
treatment, and you have to follow the
procedure explained in FTC Rule 4.9(c),
16 CFR 4.9(c). Your comment will be
kept confidential only if the FTC
General Counsel, in his or her sole
discretion, grants your request in
accordance with the law and the public
interest.
Postal mail addressed to the
Commission is subject to delay due to
heightened security screening. As a
result, we encourage you to submit your
comments online, or to send them to the
Commission by courier or overnight
service. To make sure that the
Commission considers your online
comment, you must file it at https://
ftcpublic.commentworks.com/ftc/
altfuelspra, by following the
instructions on the web-based form. If
this Notice appears at https://
www.regulations.gov/#!home, you also
may file a comment through that Web
site.
If you file your comment on paper,
write ‘‘Paperwork Comment: FTC File
No. P134200’’ on your comment and on
the envelope, and mail or deliver it to
the following address: Federal Trade
Commission, Office of the Secretary,
Room H–113 (Annex J), 600
Pennsylvania Avenue NW., Washington,
DC 20580. If possible, submit your
paper comment to the Commission by
courier or overnight service.
Visit the Commission Web site at
https://www.ftc.gov to read this Notice.
The FTC Act and other laws that the
Commission administers permit the
collection of public comments to
consider and use in this proceeding as
appropriate. The Commission will
consider all timely and responsive
public comments that it receives on or
before February 8, 2013. You can find
more information, including routine
uses permitted by the Privacy Act, in
the Commission’s privacy policy, at
https://www.ftc.gov/ftc/privacy.htm.
The FTC invites comments on: (1)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
VerDate Mar<15>2010
18:30 Dec 07, 2012
Jkt 229001
agency, including whether the
information will have practical utility;
(2) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information, including the validity of
the methodology and assumptions used;
(3) ways to enhance the quality, utility,
and clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information.
David C. Shonka,
Acting General Counsel.
[FR Doc. 2012–29734 Filed 12–7–12; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–13–0469]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Kimberly Lane, 1600
Clifton Road, MS D–74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Program of Cancer Registries
Cancer Surveillance System (OMB No.
0920–0469, exp. 11/30/2012)—
Reinstatement—National Center for
Chronic Disease Prevention and Health
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
73469
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
One of every four deaths in the United
States is attributable to cancer, making
it the second leading cause of death
among Americans. In 2009, over
1,500,000 people were diagnosed with
invasive cancer and 650,000 people
died of cancer. Living with cancer also
affects many people. In January 2008,
the National Cancer Institute estimated
that 11.9 million Americans were alive
with a history of invasive cancer.
In addition to the personal impact of
cancer, the financial burden is also
substantial. The direct treatment costs of
cancer in 2008 have been estimated at
$93.2 billion, with additional indirect
costs of $134.9 billion in lost
productivity due to illness and
premature death.
In 1992, Congress passed the Cancer
Registries Amendment Act, which
established the National Program of
Cancer Registries (NPCR). Through the
NPCR, CDC provides support for statebased central cancer registries (CCR)
that collect, manage, and analyze data
about cancer cases in their jurisdictions.
The CCR are responsible for obtaining
diagnostic and treatment information
from a variety of sources and for
reconciling this information to produce
accurate incidence and prevalence
statistics. Through the NPCR, CDC also
provides CCR with technical assistance
that supports common standards for
data definition and quality in a core set
of data items. The NPCR-funded
registries, which are located in states,
the District of Columbia, and U.S.
territories, have reported a standardized
data set to CDC annually through the
National Program of Cancer Registries
Cancer Surveillance System (NPCR
CSS)(OMB No. 0920–0469, exp. 11/30/
2012). Many registries maintain
additional data items that are not part of
the standard NPCR CSS report to CDC.
The NPCR CSS has allowed CDC to
collect, aggregate, evaluate and
disseminate cancer incidence data at the
national and state level. The NPCR CSS
is the primary source of information for
United States Cancer Statistics (USCS),
which CDC has published annually
since 2002. The latest USCS report
published in 2012 provided cancer
statistics for 98% of the United States
population from all cancer registries
whose data met national data standards.
Prior to the publication of USCS, cancer
incidence data at the national level were
available for only 14% of the population
of the United States.
CDC has also used information
reported through the NPCR CSS to
E:\FR\FM\10DEN1.SGM
10DEN1
73470
Federal Register / Vol. 77, No. 237 / Monday, December 10, 2012 / Notices
monitor cancer trends over time,
describe geographic variation in cancer
incidence throughout the country, and
provide incidence data on minority
populations and rare cancers. In
addition, data on stage at diagnosis, type
of treatment provided, and vital status
allow CDC to assess progress in
reducing morbidity and mortality from
cancer. These activities and analyses
further support CDC’s planning and
evaluation efforts for state and national
cancer control and prevention. Finally,
datasets compiled through the NPCR
CSS have been made available to
investigators for secondary analysis.
CDC plans to request OMB approval
to reinstate the NPCR CSS information
collection, with changes. First, the
frequency of reporting to CDC will be
changed from an annual to a semiannual schedule. The additional report
will allow CDC to compile preliminary
cancer incidence estimates in advance
of the lengthy process of data validation
required for each registry’s final annual
report. Second, data definitions for each
OMB approval will be requested for
three years. Respondents will be NPCRsupported central cancer registries in
U.S. states, territories, and the District of
Columbia. Information will be reported
electronically to CDC twice per year.
The first report will consist of a singleyear file for data that includes diagnoses
12 months past the close of the
diagnosis year. The second report will
consist of a cumulative file containing
incidence data from the first diagnosis
year for which the cancer registry
collected data with the assistance of
NPCR funds (e.g., 1995) through 24
months past the close of the diagnosis
year (e.g., 2010 data submitted in 2012).
The estimated burden per response is
two hours. Because cancer incidence
data are already collected, aggregated
and used for analyses at the state level,
the additional burden of reporting the
information to CDC is small and the
number of data items in the report does
not affect the estimated burden per
response. There are no costs to
respondents except their time.
report will be updated to reflect changes
in national standards for cancer
diagnosis, treatment, and coding. These
changes will affect the standard reports
for all NPCR-funded central cancer
registries.
The third set of changes applies to a
subset of 10 central cancer registries.
These CCR received ARRA funding to
develop common standards and
reporting mechanisms for enhanced
description of cases of breast cancer,
colorectal cancer, and chronic
myelogenous leukemia (CML). The
enhanced data items will support more
in-depth analysis of treatment strategies
and patient outcomes than is currently
possible with the standard NPCR CSS
information collection. The 10 registries
that participated in the enhancement
process will begin reporting the
additional data items to CDC in 2013 as
part of their routine submission. CDC
plans to make de-identified data
available for comparative effectiveness
research (CER).
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
Central Cancer Registries in States,
Territories, and the District of Columbia.
Standard NPCR CSS Report ...........
38
2
2
152
Enhanced NPCR CSS Report .........
10
2
2
40
...........................................................
........................
........................
........................
192
Total ...........................................
Dated: December 4, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
[FR Doc. 2012–29722 Filed 12–7–12; 8:45 am]
BILLING CODE 4163–18–P
Proposed Project
Congenital Syphilis Case Investigation
and Reporting Form (CDC73.126), OMB
0920–0128, Expiration 03/31/2013—
Revision—National Center for HIV,
Viral Hepatitis, STD and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-13–0128]
mstockstill on DSK4VPTVN1PROD with
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
VerDate Mar<15>2010
18:30 Dec 07, 2012
Jkt 229001
Background and Brief Description
Congenital syphilis (CS) is an
important sentinel health event that
marks potential problems in both
prenatal care and syphilis prevention
programs. Congenital syphilis (CS) is
nearly 100% preventable by early
detection and treatment of syphilis in
pregnant women before or during
pregnancy.
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Reducing congenital syphilis is a
national objective in the U.S.
Department of Health and Human
Services report entitled, ‘‘Healthy
People 2020’’.
The CDC continues to collect and
report information on congenital
syphilis morbidity as part of its ongoing
Sexually Transmitted Disease (STD)
surveillance efforts. A reporting form for
congenital syphilis (CDC Form 73.126)
was initiated in 1983 to improve
detection, case management, and
treatment of congenital syphilis cases.
Continued data collection will assist in
identifying needs for congenital syphilis
prevention efforts nationwide.
The current CS reporting form was
revised and approved by OMB in 2009
to collect information based on the
surveillance case definition and removal
of Reporting city information. It is being
used by all health jurisdictions
reporting CS to CDC as part of the
National Notifiable Diseases
Surveillance. For the new approval
period, CDC requests elimination of the
E:\FR\FM\10DEN1.SGM
10DEN1
]]>Agencies
[Federal Register Volume 77, Number 237 (Monday, December 10, 2012)]
[Notices]
[Pages 73469-73470]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-29722]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-13-0469]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to Kimberly Lane, 1600 Clifton Road, MS D-74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
National Program of Cancer Registries Cancer Surveillance System
(OMB No. 0920-0469, exp. 11/30/2012)--Reinstatement--National Center
for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
One of every four deaths in the United States is attributable to
cancer, making it the second leading cause of death among Americans. In
2009, over 1,500,000 people were diagnosed with invasive cancer and
650,000 people died of cancer. Living with cancer also affects many
people. In January 2008, the National Cancer Institute estimated that
11.9 million Americans were alive with a history of invasive cancer.
In addition to the personal impact of cancer, the financial burden
is also substantial. The direct treatment costs of cancer in 2008 have
been estimated at $93.2 billion, with additional indirect costs of
$134.9 billion in lost productivity due to illness and premature death.
In 1992, Congress passed the Cancer Registries Amendment Act, which
established the National Program of Cancer Registries (NPCR). Through
the NPCR, CDC provides support for state-based central cancer
registries (CCR) that collect, manage, and analyze data about cancer
cases in their jurisdictions. The CCR are responsible for obtaining
diagnostic and treatment information from a variety of sources and for
reconciling this information to produce accurate incidence and
prevalence statistics. Through the NPCR, CDC also provides CCR with
technical assistance that supports common standards for data definition
and quality in a core set of data items. The NPCR-funded registries,
which are located in states, the District of Columbia, and U.S.
territories, have reported a standardized data set to CDC annually
through the National Program of Cancer Registries Cancer Surveillance
System (NPCR CSS)(OMB No. 0920-0469, exp. 11/30/2012). Many registries
maintain additional data items that are not part of the standard NPCR
CSS report to CDC.
The NPCR CSS has allowed CDC to collect, aggregate, evaluate and
disseminate cancer incidence data at the national and state level. The
NPCR CSS is the primary source of information for United States Cancer
Statistics (USCS), which CDC has published annually since 2002. The
latest USCS report published in 2012 provided cancer statistics for 98%
of the United States population from all cancer registries whose data
met national data standards. Prior to the publication of USCS, cancer
incidence data at the national level were available for only 14% of the
population of the United States.
CDC has also used information reported through the NPCR CSS to
[[Page 73470]]
monitor cancer trends over time, describe geographic variation in
cancer incidence throughout the country, and provide incidence data on
minority populations and rare cancers. In addition, data on stage at
diagnosis, type of treatment provided, and vital status allow CDC to
assess progress in reducing morbidity and mortality from cancer. These
activities and analyses further support CDC's planning and evaluation
efforts for state and national cancer control and prevention. Finally,
datasets compiled through the NPCR CSS have been made available to
investigators for secondary analysis.
CDC plans to request OMB approval to reinstate the NPCR CSS
information collection, with changes. First, the frequency of reporting
to CDC will be changed from an annual to a semi-annual schedule. The
additional report will allow CDC to compile preliminary cancer
incidence estimates in advance of the lengthy process of data
validation required for each registry's final annual report. Second,
data definitions for each report will be updated to reflect changes in
national standards for cancer diagnosis, treatment, and coding. These
changes will affect the standard reports for all NPCR-funded central
cancer registries.
The third set of changes applies to a subset of 10 central cancer
registries. These CCR received ARRA funding to develop common standards
and reporting mechanisms for enhanced description of cases of breast
cancer, colorectal cancer, and chronic myelogenous leukemia (CML). The
enhanced data items will support more in-depth analysis of treatment
strategies and patient outcomes than is currently possible with the
standard NPCR CSS information collection. The 10 registries that
participated in the enhancement process will begin reporting the
additional data items to CDC in 2013 as part of their routine
submission. CDC plans to make de-identified data available for
comparative effectiveness research (CER).
OMB approval will be requested for three years. Respondents will be
NPCR-supported central cancer registries in U.S. states, territories,
and the District of Columbia. Information will be reported
electronically to CDC twice per year. The first report will consist of
a single-year file for data that includes diagnoses 12 months past the
close of the diagnosis year. The second report will consist of a
cumulative file containing incidence data from the first diagnosis year
for which the cancer registry collected data with the assistance of
NPCR funds (e.g., 1995) through 24 months past the close of the
diagnosis year (e.g., 2010 data submitted in 2012). The estimated
burden per response is two hours. Because cancer incidence data are
already collected, aggregated and used for analyses at the state level,
the additional burden of reporting the information to CDC is small and
the number of data items in the report does not affect the estimated
burden per response. There are no costs to respondents except their
time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Central Cancer Registries in Standard NPCR 38 2 2 152
States, Territories, and the CSS Report.
District of Columbia.
Enhanced NPCR 10 2 2 40
CSS Report.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 192
----------------------------------------------------------------------------------------------------------------
Dated: December 4, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI), Office of the Associate
Director for Science (OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012-29722 Filed 12-7-12; 8:45 am]
BILLING CODE 4163-18-P
